NeueHealth Inc Q3 2024 Earnings Report Preview What to Expect
| NEUE Stock | 5.07 0.12 2.42% |
About 58% of all NeueHealth's shareholders are looking to take a long position. The analysis of overall sentiment of trading NeueHealth stock suggests that some investors are interested at this time. The current market sentiment, together with NeueHealth's historical and current headlines, can help investors time the market. In addition, many technical investors use NeueHealth stock news signals to limit their universe of possible portfolio assets.
NeueHealth |
NeueHealth Inc is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is 234.89 million, and the earnings are
Read at gurufocus.com
 |
NeueHealth Fundamental Analysis
We analyze NeueHealth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeueHealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeueHealth based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
NeueHealth is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
NeueHealth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NeueHealth stock to make a market-neutral strategy. Peer analysis of NeueHealth could also be used in its relative valuation, which is a method of valuing NeueHealth by comparing valuation metrics with similar companies.
Peers
NeueHealth Related Equities
| WU | Western Union | 2.99 | ||||
| GBCI | Glacier Bancorp | 2.24 | ||||
| AFSIP | AmTrust Financial | 1.99 | ||||
| SPNT | Siriuspoint | 1.70 | ||||
| ORI | Old Republic | 0.86 | ||||
| APAM | Artisan Partners | 0.46 | ||||
| SLF | Sun Life | 0.28 | ||||
| BCBP | BCB Bancorp | 0.84 |
Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |